phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with aspirin in 4 studies
Studies (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Trials (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Recent Studies (post-2010) (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Studies (aspirin) | Trials (aspirin) | Recent Studies (post-2010) (aspirin) |
---|---|---|---|---|---|
191 | 4 | 23 | 48,947 | 6,817 | 13,778 |
Protein | Taxonomy | phenylalanyl-prolyl-arginine-chloromethyl ketone (IC50) | aspirin (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.35 | |
Integrin beta-3 | Homo sapiens (human) | 5 | |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.8252 | |
Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 1.375 | |
Integrin alpha-IIb | Homo sapiens (human) | 5 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.271 | |
Substance-P receptor | Cavia porcellus (domestic guinea pig) | 2.4 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 2.15 | |
Urotensin-2 receptor | Rattus norvegicus (Norway rat) | 0.3 | |
4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 2.4 | |
Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.35 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.4081 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Durham, SK; Heran, CL; Megill, JR; Schumacher, WA; Steinbacher, TE | 1 |
Ito, H; Kimura, Y; Ozeki, Y; Sudo, T | 1 |
André, P; Conley, PB; Delaney, SM; LaRocca, T; Lin, PH; Phillips, DR; Sinha, U; Vincent, D | 1 |
Canino, J; Canobbio, I; Guidetti, GF; Torti, M; Visconte, C; Zarà , M | 1 |
4 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and aspirin
Article | Year |
---|---|
Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Aspirin; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery Thrombosis; Dipyridamole; Fibrinolytic Agents; Heparin; Male; Oxazoles; Propionates; Rats; Rats, Sprague-Dawley; Thrombolytic Therapy; Ticlopidine; Triazoles; Warfarin | 1993 |
Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Aspirin; Blood Coagulation; Blood Platelets; Cilostazol; Collagen; Dipyridamole; Filtration; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Pressure; Tetrazoles; Time Factors; Tirofiban; Tyrosine | 2001 |
Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Antithrombins; Aspirin; Blood Coagulation; Collagen Type III; Diffusion Chambers, Culture; Drug Synergism; Eptifibatide; Factor Xa Inhibitors; Heparin; Heterocyclic Compounds; Humans; In Vitro Techniques; Membrane Proteins; Mice; Mice, Knockout; Microscopy, Video; Peptides; Perfusion; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stress, Mechanical; Thiazoles; Thrombin; Thrombosis | 2003 |
Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells.
Topics: Amino Acid Chloromethyl Ketones; Aspirin; Blood Platelets; Breast Neoplasms; Caco-2 Cells; Calcium Chloride; Colorectal Neoplasms; Female; Fibrin; Fibrinogen; Humans; Integrin alpha2; MCF-7 Cells; Platelet Activation; Platelet Aggregation; Thromboxane A2; Type C Phospholipases | 2018 |